Nasdaq ended the day without a hitch to lift the markets to a modestly higher close with the Dow gaining 46 points to 15,010. Nasdaq rose 19 points to 3657.
On the upside
Motley Fool noted that Prana Biotechnology (Nasdaq: PRAN) was testing one of the more promising drugs that could be a potential treatment for Alzheimer's disease.
Bargain hunters lifted shares of Itau Unibanco Holding (NYSE: ITUB).
Darling International (NYSE: DAR) will acquire the animal by-products recycling business of Maple Leaf Foods.
On the downside
Hibbett Sports (Nasdaq: HIBB) reported higher second quarter earnings and revenue but the sporting goods retailer lowered its full year earnings guidance.
TheStreet wrote that MannKind (Nasdaq: MNKD) was overvalued and that its Afrezza inhaler was inferior to Novo Nordisk's Novolog.
In the broad market, advancing issues outpaced decliners by a margin of nearly 7 to 3 on the NYSE and by more than 10 to 9 on Nasdaq. The broader S&P 500 rose 6 points to 1663.